Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05188729
Title Open-Label Proof of Concept Study of LTX-315 in Basal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verrica Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.